HRT FINANCIAL LP

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1475597 NEW YORK, NY

Position in SNDX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,938,393

+$5,861,596 QoQ

Shares Held

363,147

+308.5% QoQ

Ownership

0.407%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#55

of 242 holders

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $848,581,551 across 184 Biotechnology names. SNDX ranks #26 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,938,393	363,147	+308.5%	Shares	Defined	2026-08-14
2026-03-31	$2,076,797	88,904	-40.0%	Shares	Defined	2026-05-14
2025-09-30	$2,279,118	148,139	+16.5%	Shares	Defined	2025-11-14
2025-06-30	$1,190,394	127,111	-12.4%	Shares	Defined	2025-08-14
2025-03-31	$1,781,742	145,034	+38.3%	Shares	Defined	2025-05-15
2024-12-31	$1,386,513	104,880	+96.3%	Shares	Defined	2025-02-14
2024-09-30	$1,028,450	53,426	+122.5%	Shares	Defined	2024-11-12
2023-09-30	$348,610	24,009	+123.3%	Shares	Defined	2023-11-13
2023-06-30	$225,018	10,751	-75.1%	Shares	Defined	2023-08-11
2022-03-31	$749,860	43,145	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.